Synergy Pharmaceuticals – Court Confirms Modified Fourth Amended Plan as Creditors Set for 35% Recovery

April 25, 2019 – The Court hearing the Synergy Pharmaceuticals case issued an order confirming [Docket No. 713] the Debtors' modified Fourth Amended Plan [Docket No. 712]. On December 12, 2018, Synergy Pharmaceuticals (“Synergy” or the “Company”) and one affiliated Debtor filed for Chapter 11 protection with the U.S. Bankruptcy Court in the Southern District…